Gilbert Meher | Science

Welcome to April's newsletter edition, where we're taking a deep dive into #digitalpathology with expert insight from Dr. Aleks 🔬 Żuraw, founder of Digital Pathology Place, and Donal O'Shea, CEO of Deciphex. The Digital Pathology market, valued at $0.9 billion in 2023, is projected to reach $1.8 billion by 2028. Dr. Aleks 🔬and Donal shared their insights, highlighting the profound impact digital pathology could have on healthcare and life sciences research, while also examining potential obstacles to its widespread adoption. 🖱️ Click to learn more about digital pathology and read expert viewpoint on how to scale the industry. ✔️ Subscribe to hashtag #UndertheScope to stay informed on the latest in the Life Sciences and Industrial Scientific industries. #digitalpathology #pathology #lifesciences #healthcare Gilbert Meher

Welcome to the latest newsletter, where Emily Legood sat down with Tyrone Richardson, CCO of Ryght, to discuss the potential of #GenAI in the #biotech, #pharma, and #CRO sectors. The global AI in life science analytics market size is expected to reach around $5.10 billion by 2032, a significant increase from the $2 billion recorded in 2023. Tyrone shared insights into the positive impact generative AI could have on the Life Sciences and Healthcare industries, as well as outlining the potential challenges to its successful integration. 🖱️ Click to learn more about generative AI in the pharma industry and Ryght's mission to make generative AI accessible, secure, and tailored for life sciences and healthcare applications. ✔️ Subscribe to #UndertheScope to stay informed on the latest in the Life Sciences and Industrial Scientific industries. Gilbert Meher

☕ GM Science's Weekly "Short n' Sweet" News Round-Up!  We are here to keep you in the loop with all the latest happenings in Science. Stay tuned every Friday for more! This week in science:  📌 Agendia’s MammaPrint and BluePrint FFPE breast cancer tests gain EU’s CE-IVDR approval 📌 Roche invests RMB 3B ($420M) to expand diagnostics facility in Suzhou, China 📌 FDA proposes new guidelines on PCCPs for modifying medical devices including lab tests 📌 Novartis and Versant Ventures to form Borealis Biosciences, Inc. for kidney disease research 📌 #EU grants second approval for AbbVie’s TEPKINLY® in treating relapsed follicular lymphoma Anything we missed? Let us know in the comment 👀 #lifesciencenews #cancerresearch #genomic #precisionmedicine #lifescience #breastcancer

👉 GM Science's Weekly News Round-Up! We are here to keep you in the loop with all the latest happenings in Science. Stay tuned every Friday for more! This week in science:  📌 Large-scale single-cell sequencing grant program Scale Biosciences, Ultima Genomics, NVIDIA 📌 Myriad Genetics & Personalis, Inc. to expand access to MRD testing 📌 io9, Inc. AI digital pathology test shows potential to inform breast, ovarian cancer therapy 📌 Stanford University study pins 44 & 60 as key points in ageing 📌 DNAnexus, Galatea Bio Inc. collaborate to enhance genomic access for diverse populations Anything we missed? Let us know in the comment 👀 #lifesciencenews #cancerresearch #genomic #precisionmedicine #lifescience

#CRISPR, and the broader field of #geneediting, are significant topics of discussion within the Life Sciences industry, celebrated for their potential for impact on healthcare and criticised for the associated costs and risks. Ross Bundy, CEO of CRISPR QC previously gave us his insight on the topic for an installment of our newsletter, #UndertheScope. Check out highlights from the interview below, and go to CRISPR QC to see their latest exciting product launches!

🌟 𝐖𝐞𝐥𝐜𝐨𝐦𝐞 𝐭𝐨 𝐉𝐮𝐥𝐲'𝐬 𝐞𝐝𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 #𝐅𝐔𝐍𝐃𝐋𝐀𝐁! 🌟 Here are some top highlights we'd like to share 🚀: 💸 Element Biosciences raised $277 million in a Series D funding round. 💸 Artiva Biotherapeutics raised $167 million in an upsized IPO. 💸 Scorpion Therapeutics raised $150 million in a Series C financing round. 💸 CatalYm GmbH raised $150 million in an oversubscribed Series D financing round. 💸 Asceneuron SA secured $100 million in a Series C funding round. 💸 Truvian Health raised $74 million in a private financing round. 💸 Spear Bio secured $45 million in Series A financing. 💸 Predicta Biosciences raised $5.2 million in an oversubscribed seed financing round. Any funding highlights we may have missed? Share in the comments below☟ #gilbertmeher #lifesciencesfunding #biotechfunding #genomic #biotech #bioscience

🌟 𝐖𝐞𝐥𝐜𝐨𝐦𝐞 𝐭𝐨 𝐉𝐮𝐧𝐞'𝐬 𝐞𝐝𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 #𝐅𝐔𝐍𝐃𝐋𝐀𝐁! 🌟 Here are some top highlights we'd like to share 🚀: 💸 Formation Bio raised $372 million in a series D funding round. 💸Santa Ana Bio, Inc. unveiled $168 in a combined series A and B funding round. 💸BillionToOne raised $130 million in an oversubscribed Series D financing round. 💸Alzheon, Inc. | Preserving Future Memories raised $100 Million in a Series E financing round. 💸Bright Peak Therapeutics secured $90 million in a Series C funding round. 💸Moleculent raised $26M in Series A financing. 💸Alida Biosciences secured $7.5 million in Series A financing. 💸Rarity Bioscience closed a €6.5 million ($7 million) funding round. Any funding highlights we may have missed? Share in the comments below☟ #gilbertmeher #lifesciencesfunding #biotechfunding #genomic #biotech #bioscience

For this instalment of #WomenInScience, we sat down with Noeleen Donegan, the new COO of Kerry and the first woman to hold this position. Throughout her career, Noeleen has had only one female manager. She shared insights into the challenges for female leaders and explained why she views COVID-19 as a pivotal moment that fostered a more equitable workplace culture. Read on to discover how Noeleen overcame these challenges to progress to become the first COO of one of the top 10 food ingredients manufacturers globally. Gilbert Meher

Yesterday was #EqualResearchDay, created by Evvy to raise awareness in the holes in scientific and medical understanding of the female body. I'm fairly well-researched on this topic so familiar with some of the facts Evvy have shared, but seeing them written in black and white makes my jaw drop every time. They are a true highlight of how behind we are on diagnosing and treating women for both female-specific and gender agnostic conditions. Interested in learning more? Check out my interview with Pita Navarro, who shared the journey of Evvy in navigating through these challenges, and the crucial role that #data and #research play in shaping the future of women's health. Linked in comments! Gilbert Meher | Science

It's that time again, welcome to May's edition of #FUNDLAB! Let's take a look at this month's funding highlights 🚀 💸 Zenas BioPharma closed an upsized $200M Series C, led by SR One Capital Management 💸BridgeBio secured $200M to spinout BridgeBio Oncology Therapeutics 💸Attovia Therapeutics closed $105M in oversubscribed Series B 💸Karius secured $100M in Series C 💸Aardvark Therapeutics closed $85M in Series C 💸ELEGEN closed $35M in Series B, led by Triatomic Capital 💸CENTOGENE secured ~$20M from biopharmaceutical company Lifera 💸Phenomix Sciences secured $5.5M in Series A funding, alongside a NIH grant What have we missed? Comment your own highlights below ☟ Gilbert Meher